Streetbeat News

Products Services

TNXP

Tonix Pharmaceuticals Holding shares are trading lower after the company announced a $34 million agreement with the Defense Threat Reduction Agency to develop the broad-spectrum antiviral TNX-4200.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 11:58 am

BMRA

Biomerica, Inc. (NASDAQ:BMRA) has enhanced its inFoods® IBS diagnostic test with a new at-home blood collection system, allowing patients to self-collect blood samples. This innovation aims to expand access to IBS diagnostics through telehealth and online medical providers, potentially increasing revenues by reaching a broader patient population.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 11:53 am

EIPX

KEAT

TTE

TotalEnergies SE (NYSE:TTE) shares are trading higher after the company disclosed the acquisition of Tecoil, a Finnish company specializing in the production of Re-Refined Base Oils (RRBOs). Tecoil operates a facility in Finland and has a circular economy network across Europe. This acquisition aligns with TotalEnergies' strategy to enhance its lubricant offerings and reduce carbon footprint. TTE shares are up 2.47% premarket. Investors can gain exposure to TTE via ETFs like EIPX and KEAT.

Portfolio Pulse from Lekha Gupta

July 01, 2024 | 11:51 am

ARBE

Arbe Robotics shares are trading higher after the company announced it was awarded an OEM contract for next-generation radar production.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 11:47 am

VRCA

Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) has settled litigation with Dormer Laboratories, Inc., resulting in Dormer halting the sale of cantharidin-containing products in the US.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 11:42 am

DFLI

Dragonfly Energy Holdings Corp. (NASDAQ:DFLI) will provide lithium-based liftgate power solutions to Refreshment Services Pepsi, a move expected to yield cost savings and environmental benefits.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 11:40 am

NBIX

Neurocrine Biosciences' Crinecerfont has received Priority Review from the FDA for the treatment of classic congenital adrenal hyperplasia (CAH). The FDA decision is expected by the end of 2024. If approved, Crinecerfont would be the first new treatment for CAH in 70 years and a first-in-class therapy.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 11:37 am

IQ

iQIYI has announced the launch of its iQIYI XR app for the Apple Vision Pro, marking a significant step in its technological advancements and content delivery capabilities.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 11:36 am

BA

GME

LI

NIO

NVDA

QQQ

SPR

SPY

TSLA

XPEV

U.S. stocks are expected to start the week cautiously, with Nvidia likely to extend its slide, impacting tech stocks. Analyst Daniel Ives predicts a 15% gain for tech stocks in the second half of the year due to AI expansion. Key economic data and bond yields will be closely watched. Boeing fell after confirming its takeover of Spirit AeroSystems, while Tesla rose ahead of its deliveries report. Chinese EV startups saw gains, and GameStop dropped following a class action lawsuit against Roaring Kitty.

Portfolio Pulse from Shanthi Rexaline

July 01, 2024 | 11:35 am

NYAX

Nayax has launched EV CloudPay, a new payments solution specifically designed for electric vehicle (EV) chargers. This move aims to streamline payment processes for EV charging stations.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 11:34 am